These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 5506015)
21. [Clinical examination of volon-A tincture in the therapy of mycoses of the feet (Tinea pedum)]. Grimmer H Z Haut Geschlechtskr; 1970 Sep; 45(17):597-600. PubMed ID: 5455933 [No Abstract] [Full Text] [Related]
22. Strategies in the treatment of systemic fungal infections. Medoff G; Kobayashi GS N Engl J Med; 1980 Jan; 302(3):145-55. PubMed ID: 6985703 [No Abstract] [Full Text] [Related]
23. [Our therapeutic management of mycoses of the respiratory and digestive tracts]. Miloşescu P; Petrescu AD; Cerbulescu B Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(4):287-93. PubMed ID: 6211727 [No Abstract] [Full Text] [Related]
25. Use of terbinafine in rare and refractory mycoses. Revankar SG; Nailor MD; Sobel JD Future Microbiol; 2008 Feb; 3(1):9-17. PubMed ID: 18230029 [TBL] [Abstract][Full Text] [Related]
26. Butenafine: an update of its use in superficial mycoses. Gupta AK Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425 [TBL] [Abstract][Full Text] [Related]
27. Superficial mycoses: a practical approach. Commens CA Med J Aust; 1993 Apr; 158(7):470-5. PubMed ID: 8469197 [No Abstract] [Full Text] [Related]
28. Drugs for athlete's foot and tinea cruris. Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605 [No Abstract] [Full Text] [Related]
29. Chemotherapy for systemic mycoses. Hoeprich PD Prog Drug Res; 1989; 33():317-51. PubMed ID: 2687940 [No Abstract] [Full Text] [Related]
30. [New antibiotics for the treatment of systemic mycoses]. Medicina (B Aires); 1966; 26(6):355-6. PubMed ID: 5999108 [No Abstract] [Full Text] [Related]
31. Developments in systemic mycoses and antifungal chemotherapy. Wegmann T Br J Clin Pract Suppl; 1988 Feb; 57():15-9. PubMed ID: 3140869 [No Abstract] [Full Text] [Related]
32. [Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical antifungal agent in the treatment of superficial mycoses]. Queille-Roussel C; Dahan C; Duteil L; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP; Czernielewski J Therapie; 1991; 46(3):201-4. PubMed ID: 1792652 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic use of antimycotic substances]. Würsten D Schweiz Med Wochenschr; 1976 Mar; 106(13):455-9. PubMed ID: 1265460 [TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro & in vivo evaluation of tolciclate, tolnaftate, miconazole, clotrimazole & undecylenic acid against Trichophyton mentagrophytes. Wahab S; Srivastava OP; Singh NB; Gupta SK Indian J Exp Biol; 1978 Nov; 16(11):1200-2. PubMed ID: 750408 [No Abstract] [Full Text] [Related]
35. Use of topical clotrimazole in human keratomycosis. Mselle J Ophthalmologica; 2001; 215(5):357-60. PubMed ID: 11528261 [TBL] [Abstract][Full Text] [Related]
36. [Antifungal treatment of systemic mycoses, new molecules and new concepts on in vitro tests. 7th National Congress of the Spanish Society of Chemotherapy]. Rev Esp Quimioter; 2003 Sep; 16(3):332-3. PubMed ID: 14710712 [No Abstract] [Full Text] [Related]
37. Current drug therapy of systemic mycoses: a review. Yonga G East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014 [TBL] [Abstract][Full Text] [Related]
38. Experience with itraconazole in treatment of fungal infections. Cauwenbergh G; Borghys AM; Dupré K; Mariën K; Degreef H Ann Ist Super Sanita; 1987; 23(4):865-8. PubMed ID: 2837937 [No Abstract] [Full Text] [Related]